OBJECTIVES: We assess microvascular integrity as a marker of myocardial viability after coronary stenting, using only a pressure guidewire. BACKGROUND: Microvascular integrity generally is not assessed using pressure-only guidewires because the transducer lies upstream of microvasculature. We partially inflate a balloon inside a coronary stent to achieve a specific normalized pressure drop at rest (distal coronary/aortic pressure = 0.8) and then infuse a vasodilator, to render the wire sensitive to microvascular function. We hypothesize that the further decline in pressure (ΔFFR(0.8) ) predicts MRI myocardial viability. METHODS: We studied 29 subjects with acute coronary syndrome including myocardial infarction. After successful culprit stenting, the resting coronary/aortic pressure was set to 0.8 using temporary balloon obstruction. ΔFFR(0.8) was defined as 0.8-(distal coronary/aortic pressures) during adenosine-induced hyperemia. The average transmural extent of infarction was defined as the average area of MRI late gadolinium enhancement (after 2.8 ± 1.5 days) divided by the corresponding full thickness of the gadolinium enhanced sector in short axis slices, and was compared with ΔFFR(0.8) . RESULTS: ΔFFR(0.8) corresponded inversely and linearly with the average transmural extent of infarction (r(2) = 0.65, P < 0.001). We found that a transmural extent of infarction of 0.50 corresponded to a ΔFFR(0.8) threshold of 0.1, and had high sensitivity and specificity (100% and 94.4%, respectively). CONCLUSIONS: Using only an upstream pressure-sensitive guidewire and a partially obstructing balloon during pharmacologic hyperemia, we were able to predict MRI myocardial viability with high accuracy after relief of epicardial stenosis. With further validation, this may prove a useful clinical prognostic tool after percutaneous intervention.
OBJECTIVES: We assess microvascular integrity as a marker of myocardial viability after coronary stenting, using only a pressure guidewire. BACKGROUND: Microvascular integrity generally is not assessed using pressure-only guidewires because the transducer lies upstream of microvasculature. We partially inflate a balloon inside a coronary stent to achieve a specific normalized pressure drop at rest (distal coronary/aortic pressure = 0.8) and then infuse a vasodilator, to render the wire sensitive to microvascular function. We hypothesize that the further decline in pressure (ΔFFR(0.8) ) predicts MRI myocardial viability. METHODS: We studied 29 subjects with acute coronary syndrome including myocardial infarction. After successful culprit stenting, the resting coronary/aortic pressure was set to 0.8 using temporary balloon obstruction. ΔFFR(0.8) was defined as 0.8-(distal coronary/aortic pressures) during adenosine-induced hyperemia. The average transmural extent of infarction was defined as the average area of MRI late gadolinium enhancement (after 2.8 ± 1.5 days) divided by the corresponding full thickness of the gadolinium enhanced sector in short axis slices, and was compared with ΔFFR(0.8) . RESULTS: ΔFFR(0.8) corresponded inversely and linearly with the average transmural extent of infarction (r(2) = 0.65, P < 0.001). We found that a transmural extent of infarction of 0.50 corresponded to a ΔFFR(0.8) threshold of 0.1, and had high sensitivity and specificity (100% and 94.4%, respectively). CONCLUSIONS: Using only an upstream pressure-sensitive guidewire and a partially obstructing balloon during pharmacologic hyperemia, we were able to predict MRI myocardial viability with high accuracy after relief of epicardial stenosis. With further validation, this may prove a useful clinical prognostic tool after percutaneous intervention.
Authors: E Teiger; J Garot; E Aptecar; P Bosio; J Woscoboinik; J M Pernes; P Gueret; M Kern; J L Dubois-Randé; P Dupouy Journal: Eur Heart J Date: 1999-02 Impact factor: 29.983
Authors: B De Bruyne; N H Pijls; J Bartunek; K Kulecki; J W Bech; H De Winter; P Van Crombrugge; G R Heyndrickx; W Wijns Journal: Circulation Date: 2001-07-10 Impact factor: 29.690
Authors: Morton J Kern; Amir Lerman; Jan-Willen Bech; Bernard De Bruyne; Eric Eeckhout; William F Fearon; Stuart T Higano; Michael J Lim; Martijn Meuwissen; Jan J Piek; Nico H J Pijls; Maria Siebes; Jos A E Spaan Journal: Circulation Date: 2006-08-28 Impact factor: 29.690
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: Philip MacCarthy; Alexandre Berger; Ganesh Manoharan; Jozef Bartunek; Emanuele Barbato; William Wijns; Guy R Heyndrickx; Nico H J Pijls; Bernard De Bruyne Journal: J Am Coll Cardiol Date: 2005-01-18 Impact factor: 24.094
Authors: R J Kim; E Wu; A Rafael; E L Chen; M A Parker; O Simonetti; F J Klocke; R O Bonow; R M Judd Journal: N Engl J Med Date: 2000-11-16 Impact factor: 91.245
Authors: William F Fearon; Wilbert Aarnoudse; Nico H J Pijls; Bernard De Bruyne; Leora B Balsam; David T Cooke; Robert C Robbins; Peter J Fitzgerald; Alan C Yeung; Paul G Yock Journal: Circulation Date: 2004-05-10 Impact factor: 29.690
Authors: Wilbert Aarnoudse; William F Fearon; Ganesh Manoharan; Maartje Geven; Frans van de Vosse; Marcel Rutten; Bernard De Bruyne; Nico H J Pijls Journal: Circulation Date: 2004-10-04 Impact factor: 29.690
Authors: Ashkan Eftekhari; Jelmer Westra; Valérie Stegehuis; Niels Ramsing Holm; Tim P van de Hoef; Richard L Kirkeeide; Jan J Piek; K Lance Gould; Nils P Johnson; Evald Høj Christiansen Journal: Open Heart Date: 2022-04
Authors: Jun-Hyok Oh; Changhoon Kim; Jinhee Ahn; Jin Hee Kim; Mi Jin Yang; Hye Won Lee; Jung Hyun Choi; Han Cheol Lee; Kwang Soo Cha; Taek Jong Hong Journal: Korean Circ J Date: 2013-08-31 Impact factor: 3.243